FLAMVAL
Completed
201 enrolled
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Phase 2 Completed
40 enrolled 15 charts
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Completed
21 enrolled
Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer
Completed
182 enrolled
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Phase 2 Completed
42 enrolled 9 charts
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Phase 1 Completed
16 enrolled
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology
Phase NA Completed
8 enrolled
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2 Completed
42 enrolled
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
Phase 2 Completed
100 enrolled 38 charts
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Phase NA Completed
30 enrolled
FCR
Phase 2 Completed
21 enrolled 9 charts
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 1/2 Completed
33 enrolled
Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest
Phase NA Completed
28 enrolled 10 charts
Auto-LLC 2001
Phase 3 Completed
241 enrolled
FLUDATEP
Phase 1 Completed
10 enrolled
FORTIS
Phase NA Completed
60 enrolled
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
Phase NA Completed
197 enrolled 15 charts
SICG
Phase NA Completed
36 enrolled 16 charts
Inpatient SICP
Phase NA Completed
41 enrolled 15 charts
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
Phase NA Completed
20 enrolled
Safety and Feasibility of TMLI as Conditioning Regimen in Allogeneic Hematopoietic Stem-cell Transplantation
Phase NA Completed
14 enrolled
Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Phase 1/2 Completed
51 enrolled 16 charts
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
Phase 2 Completed
273 enrolled
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 1 Completed
40 enrolled 21 charts
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
Phase 2 Completed
47 enrolled 8 charts
A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL
Phase 2 Completed
27 enrolled 7 charts
VEN-OM
Phase 1 Completed
6 enrolled
IPSY
Phase NA Completed
125 enrolled
MICROSTEM
Phase 1 Completed
25 enrolled
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
Phase 1/2 Completed
55 enrolled 17 charts
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Phase 2 Completed
15 enrolled 13 charts
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
Phase 2 Completed
75 enrolled 14 charts
Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber
Completed
70 enrolled
BMT
Phase NA Completed
10 enrolled
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Completed
60 enrolled
CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia
Phase 2 Completed
56 enrolled 11 charts
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Phase NA Completed
160 enrolled
FinFit Aim 1
Completed
16 enrolled
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase 1 Completed
8 enrolled 9 charts
FRENCH-CYTO
Completed
92 enrolled
Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Phase 2 Completed
42 enrolled
Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia
Phase 1 Completed
1 enrolled
Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
Completed
232 enrolled
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Phase 1/2 Completed
87 enrolled 24 charts
CC Links- Tele
Phase NA Completed
124 enrolled
Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 1 Completed
29 enrolled
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Phase 3 Completed
800 enrolled 22 charts
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Phase 2 Completed
30 enrolled
Efficacy Analysis of Comparison of CAMS(Chinese Academy of Medical Sciences)-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
Completed
320 enrolled
LILRB4 STAR-T Cell Therapy for Monocytic Leukemia
Phase NA Completed
1 enrolled